| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 08/11/2005 | US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof |
| 08/04/2005 | WO2005070872A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 08/04/2005 | US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders |
| 08/04/2005 | US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 08/04/2005 | CA2551821A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 08/03/2005 | CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/27/2005 | EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | US20050159448 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 07/21/2005 | US20050159402 Polyarylcarboxamides useful as lipid lowering agents |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1379511B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642906A Novel arylamidine derivative or salt thereof |
| 07/19/2005 | US6919328 Derivatives of dibenz(b,e)-1,4-diazepine, dibenz(b,f)-1,4-oxazepine or dibenz(b,e)-1,4-thiazepine as enzyme inhibitors of the nitric oxide synthase (NOS) isoforms synthesized in neuronal cells and macrophages; stroke |
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005063723A1 Benzo`1,4 ! diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | CA2548318A1 Benzo-1, 4 diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof |
| 07/13/2005 | EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 07/12/2005 | US6916923 Method for synthesizing pyrazolobenzodiazepines |
| 07/12/2005 | US6916922 Acylating a cyclopentaindolemethylamine and cyclizing and reducing the product |
| 07/12/2005 | US6916812 Dietetic agents |
| 07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 07/07/2005 | WO2005061467A2 Piperazine derivatives as bradykinin antagonists |
| 07/07/2005 | WO2005037810A3 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof |
| 07/07/2005 | CA2529314A1 Piperazine derivatives and methods of use |
| 07/06/2005 | EP1549622A1 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists |
| 07/06/2005 | EP1268517B1 Process for the preparation of 3-amino-1,5-benzodiazepine derivatives |
| 07/06/2005 | CN1636011A Succinoylamino lactams as inhibitors and as a beta protein production |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058863A1 Reactive cyclic carbonates and ureas used for modifying biomolecules, polymers, and surfaces |
| 06/30/2005 | WO2005058832A1 Diacylhydrazine derivatives |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2548571A1 Diacylhydrazine derivatives |
| 06/29/2005 | EP1548011A1 Benzo[1,4]diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof |
| 06/29/2005 | EP1545545A2 COMPOUNDS WITH THE BICYCLO 4.2.1 NONANE SYSTEM FOR THE TREATMENT OF i FLAVIVIRIDAE /i INFECTIONS |
| 06/23/2005 | WO2004041258A8 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/22/2005 | EP1131039B1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/21/2005 | US6908915 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents |
| 06/16/2005 | WO2005054211A1 A method of purification of lorazepam |
| 06/16/2005 | WO2004033436A8 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
| 06/16/2005 | US20050130957 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them |
| 06/15/2005 | EP1541568A1 Reactive cyclic carbonates and ureas for the modification of biomolecules, polymeres and surfaces |
| 06/15/2005 | EP1539716A1 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 06/15/2005 | EP1539180A2 Compounds, compositions, and methods |
| 06/15/2005 | EP0975608B1 Halo-alkoxycarbonyl prodrugs |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124600 And thiones, 1-substituted with a (hetero)aryl)carbonyl group, e.g., 6-Bromo-1-[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]-8-methyl-3-(1-methylethyl)-2,4(1H,3R)-quinazolinedione; especially for use in growing and stored agronomic crops |
| 06/08/2005 | EP1537117A1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents |
| 06/08/2005 | CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/07/2005 | US6903091 Kidney diseases; hypotensive agents; blood disorders |
| 06/02/2005 | US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use |
| 06/02/2005 | US20050119227 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 06/01/2005 | EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 05/31/2005 | US6900213 Controlling fertility; contraceptives; anticancer agents |
| 05/31/2005 | US6900199 Central nervous system disorders; prevention amyloid deposits; Alzheimer's disease; Down sydrome |
| 05/26/2005 | US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes |
| 05/26/2005 | US20050113383 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113363 Hydroxyalkanoylaminolactams and related structures as inhibitors of A beta protein production |
| 05/26/2005 | US20050112693 Screening, biosynthesis of peptides |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | EP1044023B1 A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia |
| 05/25/2005 | CN1620450A Quinazoline(di) ones for invertebrate pest control |
| 05/25/2005 | CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 05/24/2005 | US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents |
| 05/19/2005 | US20050107363 administering to mammals drugs such as 5,10-dihydro-4,6,8-trihydroxy-10-(3,7,11-trimethyl-trans-2,trans-6,10-dodecatrienyl)-11H-dibenzo[b,e][1,4]diazepin-11-one, as anticarcinogenic agents |
| 05/19/2005 | US20050102769 For the oxidation dyeing of keratinous fibers, in particular human hair |
| 05/19/2005 | CA2544752A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 05/18/2005 | CN1616432A Compound, its use and pharmaceutical compositions comprising same |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/06/2005 | WO2005040144A1 Novel compounds |
| 05/06/2005 | WO2005040126A1 Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 05/06/2005 | CA2542720A1 Azabenzodiazepines as phosphodiesterase-4 inhibitors |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/03/2005 | US6887867 Psychological disorders |
| 05/03/2005 | US6887838 Bleach boosting components, compositions and laundry methods |
| 05/03/2005 | CA2157234C Stereoselective process for producing dihydro-2-3-benzodiazepine derivatives |
| 04/28/2005 | WO2005037810A2 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005011581A3 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 04/28/2005 | US20050090489 An alpha hydroxy acid or a retinoid as a bacterial fermentation product of a novel Streptomyces strain; topical antiwrinkle agents |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |